{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-005212","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.091411+00:00","generated_at":"2026-05-27T18:31:45.356668+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Oramed extends Scilex note maturity to Dec 2025; receives 3.25M Scilex shares as consideration","bullets":["Remaining principal on Tranche A Note is $7.675M; maturity extended from March 21, 2025 to December 31, 2025.","SCLX JV transferred 3,250,000 shares of Scilex common stock to Oramed as consideration for the extension.","Note covenants amended: cash sweep definition updated, and Scilex may not increase officer/director compensation while note outstanding.","Oramed may waive certain prepayments and instead direct prepayment to Tranche B Note holders.","Extension was a condition for payment deferrals under separate Tranche B Note amendments."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-005212","json":"https://secwatch.observer/filing/0001213900-25-005212.json","markdown":"https://secwatch.observer/filing/0001213900-25-005212.md","text":"https://secwatch.observer/filing/0001213900-25-005212.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025005212/0001213900-25-005212-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025005212/ea0228309-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T18:31:45.356668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}